Shilpa Medicare tanks 36% in 10 days, hits 5-yr low on weak Q1 results
For Q1FY20, the company reported 55 per cent year-on-year (YoY) drop in its consolidated net profit at Rs 15 crore, due to lower sales27-08-2019
27-08-2019
SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Brijgopal Innani24-08-2019
Shilpa Medicare Ltd - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Brijgopal Innani24-08-2019
SHILPA MEDICARE LTD. - 530549 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Shilpa Medicare Ltd has submitted to BSE a copy of Clarification is enclosed.21-08-2019
Shilpa Medicare Ltd - 530549 - Clarification sought from Shilpa Medicare Ltd
The Exchange has sought clarification from Shilpa Medicare Ltd on August 19, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.19-08-2019
Shilpa Medicare Ltd - 530549 - Intimatino Under Regulation 33 Of SEBI (LODR) Regulations 2019
with reference to the above mentioned subject it is intimated that the board of directors meeting was held on 13.08.2019 which commenced at 11 A.M. and concluded at 3:00 P.M. to inter-alia resolve Adopt unaudited standalone and consolidated financial statements for the quarter ended 30.06.2019 Take note of the limited review report13-08-2019
Shilpa Medicare Ltd - 530549 - Outcome of Board Meeting
with reference to the above mentioned subject it is intimated that the board of directors meeting was held on 13.08.2019 which commenced at 11 A.M. and concluded at 3:00 P.M. to inter-alia resolve Adopt unaudited standalone and consolidated financial statements for the quarter ended 30.06.2019 Take note of the limited review report13-08-2019
Shilpa Medicare Ltd - 530549 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
SHILPA MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2019 ,inter alia, to consider and approve With reference to the subject cited above, we wish to inform you that a meeting of the Board of Directors of Shilpa Medicare Limited will be held on Tuesday, the 13th day of August, 2019 to inter alia transact the following items of business: Approval of the unaudited Standalone and Consolidated financial results of the Company for the quarter ended 30th June 2019. This is for your information and records.05-08-2019
Shilpa Medicare Ltd - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Brijgopal Innani01-08-2019
Shilpa Medicare Ltd - 530549 - Intimation U/R 30 Of The SEBI(LODR) Regulations
This is to inform you that we have completed USFDA audit at our API site, Raichur between 22nd July 2019 and 26th July 2019. We have received Form 483 with 5 observations, with no repeat observations and any data integrity observations. The observations are mostly procedural in nature. This is for your information.29-07-2019